Advances in aromatase inhibition: clinical efficacy and tolerability in the treatment of breast cancer

Clin Cancer Res. 2001 Sep;7(9):2620-35.

Authors

A Buzdar¹, A Howell

Affiliation

¹ Department of Breast Medical Oncology, M. D., Anderson Cancer Center, University of Texas, Houston, 77030, USA.

PMID: 11555572

No abstract available

Publication types

Review

MeSH terms

Anastrozole
Androstadienes / adverse effects
Androstadienes / therapeutic use
Androstenedione / adverse effects
Androstenedione / analogs & derivatives
Androstenedione / therapeutic use
Aromatase Inhibitors*
Breast Neoplasms / drug therapy*
Enzyme Inhibitors / adverse effects
Enzyme Inhibitors / therapeutic use*
Fadrozole / adverse effects
Fadrozole / therapeutic use
Female
Headache / chemically induced
Humans
Letrozole
Nausea / chemically induced
Nitriles / adverse effects
Nitriles / therapeutic use
Treatment Outcome
Triazoles / adverse effects
Triazoles / therapeutic use
Vomiting / chemically induced

Substances

Androstadienes
Aromatase Inhibitors
Enzyme Inhibitors
Nitriles
Triazoles
vorozole
Anastrozole
Androstenedione
Letrozole
Fadrozole
exemestane
formestane